Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 1 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Breast 1

Conditions

Neoplasms 1Breast Neoplasms 1

Interventions

Standard of Care 176Blood Specimen Collection 135Exercise 121Educational Status 114Methods 108Interviews as Topic 106Surveys and Questionnaires 105Practice Guidelines as Topic 105Early Intervention, Educational 93Magnetic Resonance Spectroscopy 79Specimen Handling 78Radiosurgery 68Radiotherapy 54Palliative Care 48Biopsy 40Patient Navigation 37Control Groups 34Resistance Training 33Therapeutics 32Surgical Procedures, Operative 31Drug Therapy 31Diet Therapy 30Behavior Therapy 29Counseling 28Proton Therapy 25Acupuncture Therapy 25Nutrition Assessment 24Exercise Test 24Magnetic Resonance Imaging 23Health Promotion 22

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Long-Term Synaptic Depression × 1 year × Clear all
NCT07187752 2025-09-23

Identification of HER2-Positive Breast Cancer Molecular Characterization and Subtypes

Shandong Cancer Hospital and Institute

Phase NA Not yet recruiting
1,039 enrolled
Breast

Breast Neoplasms

NCT06055179 2025-07-01

XCHT for Irinotecan-Induced Gut Toxicities (Randomized Controlled Trial)

Guangzhou University of Traditional Chinese Medicine

Phase NA Recruiting
98 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡